Summary
The Investment Committee assessed AI's expansion into healthcare through Bristol Myers Squibb using Nvidia's system, flagged fading momentum in Boeing and caution on defense stocks like Lockheed Martin, presented contrasting views on Uber with one member eyeing a re-entry and another calling it dead money, and highlighted Charles Schwab's upcoming earnings as a potential catalyst for new all-time highs.
- Bristol Myers Squibb buying Nvidia's AI computing system underscores AI adoption in healthcare, boosting efficiency and drug development timelines.
- Boeing momentum signal has deteriorated to yellow/red, prompting avoidance despite potential earnings event.
- Lockheed Martin and defense stocks face budget headwinds and lack near-term catalysts; caution advised until midterm elections clarity.
- Uber drawdown to 60s looks interesting to one member who trimmed in 90s, watching for cash flow growth and super-app expansion.
- Another member sees Uber as dead money due to rising EV/AV competition, missed earnings, and escalating driver costs from gas prices.
- Charles Schwab's earnings seen as bullish catalyst with retail trading engagement driving net interest margin, targeting breakout above $107.5 toward $110-115.